Preservation of renal function in cardiac surgery patients with low cardiac output syndrome: levosimendan vs beta agonists
Abstract Background Some studies have been performed to assess the effects of levosimendan on cardiac function when administered to cardiac surgery patients with low cardiac output syndrome (LCOS) in the immediate postoperative period. Levosimendan is an inotropic agent for the treatment of low card...
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2019-11-01
|
| Series: | BMC Anesthesiology |
| Subjects: | |
| Online Access: | http://link.springer.com/article/10.1186/s12871-019-0888-2 |
| _version_ | 1818537250530525184 |
|---|---|
| author | Jose Luis Guerrero Orriach I. Navarro Arce P. Hernandez Rodriguez A. Raigón Ponferrada A. Malo Manso M. Ramirez Aliaga A. Ramirez Fernandez J. J. Escalona Belmonte I. Bellido Estevez A. Gomez Luque R. Barrera Serrano C. S. Toledo Medina M. Rubio Navarro J. Cruz Mañas |
| author_facet | Jose Luis Guerrero Orriach I. Navarro Arce P. Hernandez Rodriguez A. Raigón Ponferrada A. Malo Manso M. Ramirez Aliaga A. Ramirez Fernandez J. J. Escalona Belmonte I. Bellido Estevez A. Gomez Luque R. Barrera Serrano C. S. Toledo Medina M. Rubio Navarro J. Cruz Mañas |
| author_sort | Jose Luis Guerrero Orriach |
| collection | DOAJ |
| description | Abstract Background Some studies have been performed to assess the effects of levosimendan on cardiac function when administered to cardiac surgery patients with low cardiac output syndrome (LCOS) in the immediate postoperative period. Levosimendan is an inotropic agent for the treatment of low cardiac output syndrome that seems to have a protective effect on renal function. Methods It is a quasi-experimental study. A total of 100 patients with LCOS received either beta-agonists or levosimendan. We assessed the incidence of postoperative kidney failure in cardiac surgery patients. In patients who had kidney failure at diagnosis of LCOS, we examined whether differences existed in the evolution of kidney failure based on the treatment administered for LCOS. The parameters measured included haemodynamics, oxygen supply, and renal function as assessed by the AKI scale. ANOVA, Student’s t-test and Wilcoxon or Friedman tests were used. Results Up to 30% of cardiac surgery patients had kidney failure at diagnosis of LCOS. Kidney failure at discharge from the ICU was more frequent in patients who received beta-agonist drugs as compared to those who received levosimendan (p < 0.05). Conclusion The incidence of kidney failure decreased with the postoperative administration of levosimendan to cardiac surgery patients with LCOS, as compared to beta-agonists. Trial registration Current Controlled Trials ISRCTN 46058317. Date of registration: 7/10/2019. Retrospectively registered. |
| first_indexed | 2024-12-11T18:48:21Z |
| format | Article |
| id | doaj.art-10d0b5e72e884792803d7c49295a26a6 |
| institution | Directory Open Access Journal |
| issn | 1471-2253 |
| language | English |
| last_indexed | 2024-12-11T18:48:21Z |
| publishDate | 2019-11-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Anesthesiology |
| spelling | doaj.art-10d0b5e72e884792803d7c49295a26a62022-12-22T00:54:23ZengBMCBMC Anesthesiology1471-22532019-11-011911810.1186/s12871-019-0888-2Preservation of renal function in cardiac surgery patients with low cardiac output syndrome: levosimendan vs beta agonistsJose Luis Guerrero Orriach0I. Navarro Arce1P. Hernandez Rodriguez2A. Raigón Ponferrada3A. Malo Manso4M. Ramirez Aliaga5A. Ramirez Fernandez6J. J. Escalona Belmonte7I. Bellido Estevez8A. Gomez Luque9R. Barrera Serrano10C. S. Toledo Medina11M. Rubio Navarro12J. Cruz Mañas13Institute of Biomedical Research in Malaga [IBIMA]Department of Anaesthesiology, Virgen de la Victoria University HospitalDepartment of Anaesthesiology, Virgen de la Victoria University HospitalInstitute of Biomedical Research in Malaga [IBIMA]Institute of Biomedical Research in Malaga [IBIMA]Institute of Biomedical Research in Malaga [IBIMA]Institute of Biomedical Research in Malaga [IBIMA]Institute of Biomedical Research in Malaga [IBIMA]Institute of Biomedical Research in Malaga [IBIMA]Institute of Biomedical Research in Malaga [IBIMA]Department of Anaesthesiology, Virgen de la Victoria University HospitalDepartment of Anaesthesiology, Virgen de la Victoria University HospitalInstitute of Biomedical Research in Malaga [IBIMA]Institute of Biomedical Research in Malaga [IBIMA]Abstract Background Some studies have been performed to assess the effects of levosimendan on cardiac function when administered to cardiac surgery patients with low cardiac output syndrome (LCOS) in the immediate postoperative period. Levosimendan is an inotropic agent for the treatment of low cardiac output syndrome that seems to have a protective effect on renal function. Methods It is a quasi-experimental study. A total of 100 patients with LCOS received either beta-agonists or levosimendan. We assessed the incidence of postoperative kidney failure in cardiac surgery patients. In patients who had kidney failure at diagnosis of LCOS, we examined whether differences existed in the evolution of kidney failure based on the treatment administered for LCOS. The parameters measured included haemodynamics, oxygen supply, and renal function as assessed by the AKI scale. ANOVA, Student’s t-test and Wilcoxon or Friedman tests were used. Results Up to 30% of cardiac surgery patients had kidney failure at diagnosis of LCOS. Kidney failure at discharge from the ICU was more frequent in patients who received beta-agonist drugs as compared to those who received levosimendan (p < 0.05). Conclusion The incidence of kidney failure decreased with the postoperative administration of levosimendan to cardiac surgery patients with LCOS, as compared to beta-agonists. Trial registration Current Controlled Trials ISRCTN 46058317. Date of registration: 7/10/2019. Retrospectively registered.http://link.springer.com/article/10.1186/s12871-019-0888-2LevosimendanLow cardiac outputKidneyCardiac surgery |
| spellingShingle | Jose Luis Guerrero Orriach I. Navarro Arce P. Hernandez Rodriguez A. Raigón Ponferrada A. Malo Manso M. Ramirez Aliaga A. Ramirez Fernandez J. J. Escalona Belmonte I. Bellido Estevez A. Gomez Luque R. Barrera Serrano C. S. Toledo Medina M. Rubio Navarro J. Cruz Mañas Preservation of renal function in cardiac surgery patients with low cardiac output syndrome: levosimendan vs beta agonists BMC Anesthesiology Levosimendan Low cardiac output Kidney Cardiac surgery |
| title | Preservation of renal function in cardiac surgery patients with low cardiac output syndrome: levosimendan vs beta agonists |
| title_full | Preservation of renal function in cardiac surgery patients with low cardiac output syndrome: levosimendan vs beta agonists |
| title_fullStr | Preservation of renal function in cardiac surgery patients with low cardiac output syndrome: levosimendan vs beta agonists |
| title_full_unstemmed | Preservation of renal function in cardiac surgery patients with low cardiac output syndrome: levosimendan vs beta agonists |
| title_short | Preservation of renal function in cardiac surgery patients with low cardiac output syndrome: levosimendan vs beta agonists |
| title_sort | preservation of renal function in cardiac surgery patients with low cardiac output syndrome levosimendan vs beta agonists |
| topic | Levosimendan Low cardiac output Kidney Cardiac surgery |
| url | http://link.springer.com/article/10.1186/s12871-019-0888-2 |
| work_keys_str_mv | AT joseluisguerreroorriach preservationofrenalfunctionincardiacsurgerypatientswithlowcardiacoutputsyndromelevosimendanvsbetaagonists AT inavarroarce preservationofrenalfunctionincardiacsurgerypatientswithlowcardiacoutputsyndromelevosimendanvsbetaagonists AT phernandezrodriguez preservationofrenalfunctionincardiacsurgerypatientswithlowcardiacoutputsyndromelevosimendanvsbetaagonists AT araigonponferrada preservationofrenalfunctionincardiacsurgerypatientswithlowcardiacoutputsyndromelevosimendanvsbetaagonists AT amalomanso preservationofrenalfunctionincardiacsurgerypatientswithlowcardiacoutputsyndromelevosimendanvsbetaagonists AT mramirezaliaga preservationofrenalfunctionincardiacsurgerypatientswithlowcardiacoutputsyndromelevosimendanvsbetaagonists AT aramirezfernandez preservationofrenalfunctionincardiacsurgerypatientswithlowcardiacoutputsyndromelevosimendanvsbetaagonists AT jjescalonabelmonte preservationofrenalfunctionincardiacsurgerypatientswithlowcardiacoutputsyndromelevosimendanvsbetaagonists AT ibellidoestevez preservationofrenalfunctionincardiacsurgerypatientswithlowcardiacoutputsyndromelevosimendanvsbetaagonists AT agomezluque preservationofrenalfunctionincardiacsurgerypatientswithlowcardiacoutputsyndromelevosimendanvsbetaagonists AT rbarreraserrano preservationofrenalfunctionincardiacsurgerypatientswithlowcardiacoutputsyndromelevosimendanvsbetaagonists AT cstoledomedina preservationofrenalfunctionincardiacsurgerypatientswithlowcardiacoutputsyndromelevosimendanvsbetaagonists AT mrubionavarro preservationofrenalfunctionincardiacsurgerypatientswithlowcardiacoutputsyndromelevosimendanvsbetaagonists AT jcruzmanas preservationofrenalfunctionincardiacsurgerypatientswithlowcardiacoutputsyndromelevosimendanvsbetaagonists |